Ruchir Rastogi

Lead Strategy at Premas Biotech

Role: Lead Strategy at Premas Biotech
Location: Delhi, IN
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Ruchir Rastogi

Diligent professional with over 10+ years of expertise in protein expression, Cell biology, Molecular biology, Vaccine design and development, pre-clinical efficacy and tox studies and assay development. Goal- oriented and proactive, discovering and securing opportunities as well as delivering effective solutions for wide scientific challenges.

Experience

Lead Strategy
Premas Biotech
Aug 2021 — Present

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@premasbiotech.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Premas Biotech

Biotechnology Research · 195 employees · Founded 2005 · Gurgaon, India

Premas is developing transformational technologies and partnering with pharmaceutical companies around the world to expedite their drug discovery programs by cutting down significantly both on costs & time to clinics. Axtex-4D, a three-dimensional cell culture platform, engineered to produce high-throughput screens for targeted immuno-oncology drug candidates, is compelling scientists to relook at their tumor-targeting strategies. The ex-vivo culture systematically mirrors the in-vivo tumor microenvironment and is poised to revolutionize both drug discovery & combinatorial therapies. D-Crypt, a platform for 'difficult-to-express’ proteins, is designed to considerably reduce time, cost, and risks associated with producing high-quality recombinant proteins. D-Crypt combines a yeast expression host with over 20 custom-made expression vectors. C-Qwence, our naive India-based Antibody Library is harnessing the power of a genetic pool that is more diverse than any other region and has exposures to infectious diseases and changes in an environment not seen in Europe or America. C-Qwence captures a wealth of novel genetics and protective immune responses, demonstrated in the unique profiles of individual antibodies isolated from the libraries. Combining our breakthrough technologies with state-of-the-art Gene to IND biologics development capabilities, Premas is seeking new partnerships with pharmaceutical companies to help accelerate the delivery of new medicines to patients.

premasbiotech.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.